SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing significant selling pressure and heightened volatility, as traders actively debate whether the stock is a long-term value opportunity or stuck in a "trough of chaos." Community sentiment remains deeply divided, with many expressing frustration over the stock's persistent decoupling from broader market rallies while focusing heavily on the implications of heavy AI infrastructure spending and ongoing antitrust scrutiny.

The Shrimp Army

The Shrimp Army is gaining traction as part of a broader trend of sea-themed memecoins, sparking intense debate among community members over its potential for rapid growth versus risks of being a speculative pump-and-dump. Traders are actively monitoring the token's ability to maintain upward momentum and consolidate at higher valuation levels.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is facing intense downward pressure driven by regulatory headwinds, specifically the potential state and federal restrictions on prediction markets, alongside ongoing legal challenges regarding trademark usage and addiction concerns. The community is actively debating the stock's long-term viability, with many retail traders expressing frustration over persistent insider selling and a lack of clear support levels.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech100 is drawing significant investor attention as the primary proxy for the highly anticipated SpaceX IPO, with community members actively debating the fund's premium-to-NAV compared to alternative holdings. The surge in volume and social sentiment reflects a strategic rotation by retail traders seeking concentrated exposure to private tech unicorns like SpaceX, Anthropic, and OpenAI ahead of potential liquidity events.

PRIME is the native token of the Echelon Prime Foundation, a Web3 ecosystem advancing the next generation of gaming. Echelon creates and distributes tools to encourage innovation in, and promote the growth of, novel gaming models and economies. The first game to adopt and utilize PRIME is Parallel, a sci-fi trading card game.

Echelon Prime

Echelon Prime is trending as community members point to signs of quiet accumulation and a potential bullish reversal for the gaming token. Traders are actively debating the token's role in the future of on-chain gaming economies, with sentiment divided between optimism for a recovery and frustration over recent volatility.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is facing intense volatility and selling pressure following a aggressive short report from Culper Research that alleges the company is engaged in channel stuffing and misleading financial reporting. While the company has officially pushed back, dismissing the claims as inaccurate and speculative, the community remains divided and highly anxious, with long-term supporters debating whether to hold through the uncertainty or exit as they wait for more substantial management responses and potential insider buying.

Fundrise Growth Tech Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is trending as investors debate whether the fund's parabolic run is driven by genuine exposure to high-growth AI and aerospace giants like SpaceX and Anthropic or if it has entered bubble territory due to its massive premium to Net Asset Value. The community remains sharply divided, with many actively hunting for alternative "catch-up" plays like DXYZ and RVI while others warn of a potential liquidity trap once lock-up periods expire.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is generating significant buzz ahead of an upcoming AAD conference late-breaking session, where the community expects positive 40-week efficacy data to confirm SLK as a best-in-class treatment for Hidradenitis Suppurativa. Investors are closely monitoring analyst upgrades, potential M&A activity, and institutional accumulation, hoping the data will finally put persistent buyout rumors and clinical skepticism to rest.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is currently experiencing high volatility following a quarterly earnings report that featured a revenue and EPS beat alongside raised full-year guidance, though initial market reaction was cautious. The community is actively debating the stock's high valuation relative to its growth phase, with many bullish traders highlighting its critical role in AI infrastructure and data center CPU expansion as reasons to buy the dip, while others express concerns over potential overvaluation and broad tech sector cooling.

Intercontinental Exchange, Inc. engages in the provision of market infrastructure, data services and technology solutions. It operates through the following segments: Exchanges, Fixed Income and Data Services, and Mortgage Technology. The Exchanges segment operates marketplace technology for the listing, trading, and clearing of derivatives contracts and financial securities, as well as data and connectivity services. The Fixed Income and Data Services segment provides fixed income pricing, reference data, indices, analytics, and execution services as well as global credit default swap, or CDS, clearing, and multi-asset class data delivery technology. The Mortgage Technology segment provides a technology platform that offers digital workflow tools to address inefficiencies and mitigate risks that exist in the US residential mortgage market lifecycle from application through closing, servicing, and the secondary market. The company was founded by Jeffrey C. Sprecher in 2000 and is headquartered in Atlanta, GA.

Intercontinental Exchange Inc

Intercontinental Exchange (ICE) is currently the focus of market attention due to its strategic push into tokenized securities and its high-profile investment in Polymarket, which signals a broader Wall Street pivot toward on-chain infrastructure. Traders are closely monitoring the stock's potential for growth as the NYSE owner leans into digital asset innovation and institutional crypto adoption, with community sentiment shifting between excitement over these technological partnerships and caution regarding broader market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Promis Neurosciences (NASDAQ:PMN) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Promis Neurosciences (NASDAQ:PMN - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the four brokerages that are covering the stock, MarketBeat.com reports. One...

Insider Buying: Promis Neurosciences (NASDAQ:PMN) Director Buys 1,000 Shares of Stock

Promis Neurosciences (NASDAQ:PMN - Get Free Report) Director Eugene Williams purchased 1,000 shares of the firm's stock in a transaction on Monday, March 2nd. The stock was bought at an average cost...

Eugene Williams Acquires 1,000 Shares of Promis Neurosciences (NASDAQ:PMN) Stock

Promis Neurosciences (NASDAQ:PMN - Get Free Report) Director Eugene Williams bought 1,000 shares of the company's stock in a transaction dated Monday, March 2nd. The stock was purchased at an average...

Promis Neurosciences (NASDAQ:PMN) Director Eugene Williams Buys 2,000 Shares

Promis Neurosciences (NASDAQ:PMN - Get Free Report) Director Eugene Williams purchased 2,000 shares of the company's stock in a transaction that occurred on Wednesday, March 4th. The shares were...

Promis Neurosciences (NASDAQ:PMN) Insider Buys $25,005.15 in Stock

Promis Neurosciences (NASDAQ:PMN - Get Free Report) insider Johanne Kaplan bought 1,629 shares of Promis Neurosciences stock in a transaction on Thursday, February 19th. The shares were purchased at...

Insider Buying: Promis Neurosciences (NASDAQ:PMN) Major Shareholder Acquires 700,741 Shares of Stock

Promis Neurosciences (NASDAQ:PMN - Get Free Report) major shareholder Abg Management Ltd. bought 700,741 shares of the company's stock in a transaction that occurred on Tuesday, February 3rd. The...

ProMIS Neurosciences Secures $175 Mln In Private Financing

(RTTNews) - ProMIS Neurosciences Inc. (PMN), a clinical-stage biotechnology company, has announced on Friday a private investment in public equity financing of up to approximately $175 million...

ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease. The company was founded by Neil Cashman and Vigen Nazarian on January 23, 2004 and is headquartered in Toronto, Canada.

Current Price	$15.85
Prev Close	$17.43
Open	$17.44
Dividend Yield	0.00%
50-Day Moving Average	$15.97
Beta	0.42
Avg. Volume	67,381.48
PE Ratio	-0.85

52-Week High	$39.75
52-Week Low	$6.27
Market Capitalization	$34.12M
EPS (Annual)	$2.63
Price to Book	3.71
Revenue Per Employee	$0.00

PMN
ProMIS Neurosciences

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PMN News

PMNProMIS Neurosciences